MEAKSS, a synthetic heptapeptide, is emerging as a promising agent for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates remarkable restorative effects by modulating key cellular pathways involved in neuronal maintenance. Studies suggest that MEAKSS can stimulate synaptogenesis, {reduceoxidative stress, and augme